Bicara Therapeutics

United States
Primghar, Iowa, United States, 02142

Company profile

Bicara Therapeutics company profile

Bicara Therapeutics is a clinical-stage biotechnology startup focused on developing dual-action biologics. The business is developing bifunctional antibodies that are designed to deliver an immunomodulatory payload directly to the tumor microenvironment, assisting cancer patients in increasing immune cell activity and potentially providing long-term efficacy.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2020-01-01, Year

Headquarters

Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$313M
Last funding
Series C / $165M / 2023-12-12
Last equity funding
Series C / $165M
Investors
19
Lead investors
6
Founders
1
Articles
145
Exited on
2024-09-13

Founders and investors

Founders

Claire Mazumdar

Lead investors

BioconBraidwellRA Capital ManagementRed Tree Venture CapitalThe Rise FundTPG

Investors

F-PrimeJanus Henderson InvestorsOmega FundsRA Capital ManagementTPG